← Leaderboards
Colton Joseph Lloyd
Sinopia Biosciences, Inc.
$2,700,762
Attributed
$2,700,762
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2022–25$2M$1.5M$1M$500K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,700,762 · 2
By mechanism
R44$2,382,478 · 1
R43$318,284 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Small Molecule”
- Kevin V Grimes · Stanford University$14,783,804
- Samuel W Teitelbaum · Arizona State University$13,377,213
- Colin Osborne · University Of Texas Med Br Galveston$10,407,745
- Taleen Hanania · Psychogenics, Inc.$9,482,040
- Sabrina Paganoni · Massachusetts General Hospital$9,298,517
- Suma Babu · Massachusetts General Hospital$9,298,517
Research focus
Small MoleculePre-Clinical AssessmentOral MucositisSide EffectChemotherapyRadiation TherapyMucositisOral CavityRadiationSeveritiesSolid NeoplasmBiological SciencesGastrointestinalEsophagusHealth Care CostsInflammationCancer TherapyOralFda ApprovedBromodomainBrd2 GeneCommon TreatmentFunctional DisorderGene Expression
Grant awards (4)
Preclinical assessment of a novel compound for treating radiation-induced oral mucositis$849,193
R44 · FY2025 · DE · contact PI
Preclinical assessment of a novel compound for treating radiation-induced oral mucositis$39,650
R44 · FY2025 · DE · contact PI
Preclinical assessment of a novel compound for treating radiation-induced oral mucositis$1,493,635
R44 · FY2024 · DE · contact PI
Preclinical assessment of a novel compound for treating radiation-induced oral mucositis$318,284
R43 · FY2022 · DE · contact PI